APO-OLMESARTAN/AMLODIPINE 20/5 olmesartan medoxomil 20 mg and amlodipine (as besilate) 5 mg tablet bottle

Country: Australia

Language: English

Source: Department of Health (Therapeutic Goods Administration)

Buy It Now

Active ingredient:

amlodipine besilate, Quantity: 6.935 mg; olmesartan medoxomil, Quantity: 20 mg

Available from:

Arrotex Pharmaceuticals Pty Ltd

INN (International Name):

amlodipine besilate,Olmesartan medoxomil

Pharmaceutical form:

Tablet

Composition:

Excipient Ingredients: magnesium stearate; powdered cellulose; purified talc; titanium dioxide; microcrystalline cellulose; polyvinyl alcohol; macrogol 8000; silicon dioxide; croscarmellose sodium

Administration route:

Oral

Units in package:

30, 1000

Prescription type:

(S4) Prescription Only Medicine

Therapeutic indications:

Olmesartan and amlodipine combination tablets are indicated for the treatment of hypertension. Treatment should not be initiated with this fixed-dose combination (see Dosage and administration).

Product summary:

Visual Identification: White coloured, round shaped, biconvex, film coated tablets with "APO" engraved on one side and "20 over 5" on the other side.; Container Type: Bottle; Container Material: HDPE; Container Life Time: 24 Months; Container Temperature: Store below 30 degrees Celsius

Authorization status:

Licence status A

Authorization date:

2016-01-12